本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (3236)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 21, 2025 (publication date) through Mar 31, 2026
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Gastroenterology
ISSN
1007-9327
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Al Awadhi S, Al Hassani A, El Ouali S, Alam MB, Azar C, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani RA, Quraishi MN. Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease. World J Gastroenterol 2025; 31(35): 109882 [PMID: 41024766 DOI: 10.3748/wjg.v31.i35.109882] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Al Awadhi S, Al Hassani A, El Ouali S, Alam MB, Azar C, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani RA, Quraishi MN. Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease. World J Gastroenterol 2025; 31(35): 109882 [PMID: 41024766 DOI: 10.3748/wjg.v31.i35.109882] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v31/i35/109882.htm |
| 编号 | Citing Articles |
| 1 |
Ajay Gade, Alessandra Saraga, Alfonso Elosua, Antony Ishan, Tina Deyhim, Nathan David Vanshelboym Rothschild, Adam S. Cheifetz, Konstantinos Papamichael. Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel disease. Expert Review of Clinical Pharmacology 2026; 19(2): 167 doi: 10.1080/17512433.2026.2630758
|